Residual Dyspnea May Predict Small Airways Dysfunction and Poor Responsiveness to Single-Inhaler Triple Therapy in Asthmatic Patients

References

• Global Initiative for Asthma. Global strategy for asthma management and prevention; 2022. Available from: https://ginasthma.org/gina-reports/. Accessed October 5, 2022.
   Google Scholar
• Adachi M, Hozawa S, Nishikawa M, Yoshida A, Jinnai T, Tamura G. Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2). J Asthma. 2019;56(9):1016–1025. doi:10.1080/02770903.2018.1514628
   PubMed Web of Science ®Google Scholar
• Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010;363(18):1715–1726. doi:10.1056/NEJMoa1008770
   PubMed Web of Science ®Google Scholar
• Kerstjens HA, Casale TB, Bleecker ER, et al. Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. Lancet Respir Med. 2015;3(5):367–376. doi:10.1016/S2213-2600(15)00031-4
   PubMed Web of Science ®Google Scholar
• Paggiaro P, Halpin DMG, Buhl R, et al. The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial. J Allergy Clin Immunol Pract. 2016;4(1):104–113.e2. doi:10.1016/j.jaip.2015.08.017
   PubMed Web of Science ®Google Scholar
• Kerstjens HAM, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367(13):1198–1207. doi:10.1056/NEJMoa1208606
   PubMed Web of Science ®Google Scholar
• Ohta K, Ichinose M, Tohda Y, et al. Long-term once-daily tiotropium respimat® is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study. PLoS One. 2015;10(4):e0124109. doi:10.1371/journal.pone.0124109
   PubMed Web of Science ®Google Scholar
• Tamada T, Sugiura H, Takahashi T, et al. Coexisting COPD in elderly asthma with fixed airflow limitation: assessment by DLco %predicted and HRCT. J Asthma. 2017;54(6):606–615. doi:10.1080/02770903.2016.1247168
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Hamada K, Oishi K, Yano M, Yamaji Y, Hirano T. Factors Associated with physician-patient discordance in the perception of asthma control. J Allergy Clin Immunol Pract. 2019;7(8):2634–2641. doi:10.1016/j.jaip.2019.04.046
   PubMed Web of Science ®Google Scholar
• Nagase H, Adachi M, Matsunaga K, et al. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan. Allergol Int. 2020;69(1):53–60. doi:10.1016/j.alit.2019.06.003
   PubMed Web of Science ®Google Scholar
• Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938. doi:10.1016/j.rmed.2011.01.005
   PubMed Web of Science ®Google Scholar
• Kerstjens HAM, Maspero J, Chapman KR, et al. Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study. Lancet Respir Med. 2020;8(10):1000–1012. doi:10.1016/S2213-2600(20)30190-9
   PubMed Web of Science ®Google Scholar
• Lee LA, Bailes Z, Barnes N, et al. Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med. 2021;9(1):69–84. doi:10.1016/S2213-2600(20)30389-1
   PubMed Web of Science ®Google Scholar
• Zhang S, King D, Rosen VM, Ismaila A. Impact of single combination inhaler versus multiple inhalers to deliver the same medications for patients with asthma or COPD: a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:417–438. doi:10.2147/COPD.S234823
   PubMed Web of Science ®Google Scholar
• Peters SP, Bleecker ER, Kunselman SJ, et al. Predictors of response to tiotropium versus salmeterol in adults with asthma. J Allergy Clin Immunol. 2013;132(5):1068–1074. doi:10.1016/j.jaci.2013.08.003
   PubMed Web of Science ®Google Scholar
• Kerstjens HAM, Moroni-Zentgraf P, Tashkin DP, et al. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status. Respir Med. 2016;117:198–206. doi:10.1016/j.rmed.2016.06.013
   PubMed Web of Science ®Google Scholar
• Casale TB, Bateman ED, Vandewalker M, et al. Tiotropium respimat add-on is efficacious in symptomatic asthma, independent of T2 phenotype. J Allergy Clin Immunol Pract. 2018;6(3):923–935.e9. doi:10.1016/j.jaip.2017.08.037
   PubMed Web of Science ®Google Scholar
• Casale TB, Aalbers R, Bleeker ER, et al. Tiotropium respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics. Respir Med. 2019;158:97–109. doi:10.1016/j.rmed.2019.09.014
   PubMed Web of Science ®Google Scholar
• Singh D, Virchow JC, Canonica GW, et al. Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER. Respir Res. 2020;21(1):285. doi:10.1186/s12931-020-01558-y
   PubMed Web of Science ®Google Scholar
• Singh D, Virchow JC, Canonica GW, et al. Extrafine triple therapy in patients with asthma and persistent airflow limitation. Eur Respir J. 2020;56(3):2000476. doi:10.1183/13993003.00476-2020
   PubMed Web of Science ®Google Scholar
• Bousquet J, Siergiejko Z, Swiebocka E, et al. Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma. Allergy. 2011;66:671–678. doi:10.1111/j.1398-9995.2010.02522.x
   PubMed Web of Science ®Google Scholar
• Hoshino Y, Koya T, Kagamu H, et al. Effect of inhaled corticosteroids on bronchial asthma in Japanese athletes. Allergol Int. 2015;64:145–149. doi:10.1016/j.alit.2014.10.004
   PubMed Web of Science ®Google Scholar
• Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005;26:153–161. doi:10.1183/09031936.05.00034505
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/rccm.9120-11ST
   PubMed Web of Science ®Google Scholar
• Inoue H, Niimi A, Takeda T, et al. Pathophysiological characteristics of asthma in the elderly: a comprehensive study. Ann Allergy Asthma Immunol. 2014;113(5):527–533. doi:10.1016/j.anai.2014.08.002
   PubMed Web of Science ®Google Scholar
• To M, Hitani A, Kono Y, et al. Obesity-associated severe asthma in an adult Japanese population. Respir Investig. 2018;56(6):440–447. doi:10.1016/j.resinv.2018.07.003
   PubMed Web of Science ®Google Scholar
• Nadif R, Siroux V, Oryszczyn MP, et al. Heterogeneity of asthma according to blood inflammatory patterns. Thorax. 2009;64(5):374–380. doi:10.1136/thx.2008.103069
   PubMed Web of Science ®Google Scholar
• Lipworth B, Manoharan A, Anderson W. Unlocking the quiet zone: the small airway asthma phenotype. Lancet Respir Med. 2014;2(6):497–506. doi:10.1016/S2213-2600(14)70103-1
   PubMed Web of Science ®Google Scholar
• Postma DS, Brightling C, Baldi S, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7(5):402–416. doi:10.1016/S2213-2600(19)30049-9
   PubMed Web of Science ®Google Scholar
• McFadden ER. Exertional dyspnea and cough as preludes to acute attacks of bronchial asthma. N Engl J Med. 1975;292:555–559. doi:10.1056/NEJM197503132921103
   PubMed Web of Science ®Google Scholar
• Rogliani P, Ritondo BL, Puxeddu E, Cazzola M, Calzetta L. Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: a systematic review. Respir Med. 2021;189:106639. doi:10.1016/j.rmed.2021.106639
   PubMed Web of Science ®Google Scholar
• Kumawat K, Koopmans T, Gosens R. β-catenin as a regulator and therapeutic target for asthmatic airway remodeling. Expert Opin Ther Targets. 2014;18(9):1023–1034. doi:10.1517/14728222.2014.934813
   PubMed Web of Science ®Google Scholar
• Hsiao YH, Tseng CM, Su KC, et al. Glycopyrronium bromide inhibits lung inflammation and small airway remodeling induced by subchronic cigarette smoke exposure in mice. Respir Physiol Neurobiol. 2018;249:16–22. doi:10.1016/j.resp.2017.12.005
   PubMed Web of Science ®Google Scholar
• Jabbal S, Cr K, Lipworth B. Randomized controlled trial of triple versus dual inhaler therapy on small airways in smoking asthmatics. Clin Exp Allergy. 2020;50:1140–1147. doi:10.1111/cea.13702
   PubMed Web of Science ®Google Scholar
• Virchow JC, Kuna P, Paggiaro P, et al. Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials. Lancet. 2019;394(10210):1737–1749. doi:10.1016/S0140-6736(19)32215-9
   PubMed Web of Science ®Google Scholar
• Agusti A, Fabbri L, Lahousse L, Singh D, Papi A. Single inhaler triple therapy (SITT) in asthma: systematic review and practice implications. Allergy. 2021;70:1–9. doi:10.15036/arerugi.70.1
   PubMedGoogle Scholar
• Cheng WC, Wu BR, Liao WC, et al. Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: a real-life study. J Thorac Dis. 2018;10(6):3661–3669. doi:10.21037/jtd.2018.05.139
   PubMed Web of Science ®Google Scholar
• Ikeda T, Anisuzzaman ASM, Yoshiki H, et al. Regional quantification of muscarinic acetylcholine receptors and β-adrenoceptors in human airways. Br J Pharmacol. 2012;166(6):1804–1814. doi:10.1111/j.1476-5381.2012.01881.x
   PubMed Web of Science ®Google Scholar
• Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339–343. doi:10.1136/thorax.58.4.339
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
   PubMed Web of Science ®Google Scholar
• Crawford B, Monz B, Hohlfeld J, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545–1555. doi:10.1016/j.rmed.2008.06.009
   PubMed Web of Science ®Google Scholar
• Vertigan AE, Kapela S, Birring SS, Gibson PG. Feasibility and clinical utility of ambulatory cough monitoring in an outpatient clinical setting: a real-world retrospective evaluation. ERJ Open Res. 2021;7:00319–2021. doi:10.1183/23120541.00319-2021
   PubMedGoogle Scholar